Hanlon Suzanne M. 4
4 · Zynerba Pharmaceuticals, Inc. · Filed Jan 16, 2018
Insider Transaction Report
Form 4
Hanlon Suzanne M.
General Counsel
Transactions
- Award
Stock Option (right to buy)
2018-01-11+42,700→ 42,700 totalExercise: $11.71Exp: 2028-01-11→ Common Stock (42,700 underlying)
Footnotes (1)
- [F1]The stock option vests 25% on the first anniversary of the date of the grant, with the remainder vesting in 12 equal quarterly installments thereafter, subject to continued employment with the Company.